Cervical intraepithelial lesions in adolescents: Cytological findings from 1999 to 2005 in Rio de Janeiro, Brazil;Lesões intra-epiteliais cervicais em adolescentes: Estudo dos achados citológicos entre 1999 e 2005, no Município do Rio de Janeiro, Brasil

Cadernos de Saude Publica

Volumn 24, Issue 12, 2008, Pages 2881-2890

  Pedrosa, Michele Lopes ^a,b   Mattos, Inês Echenique ^a   Koifman, Rosalina Jorge ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Adolescent; Uterine cervical neoplasms; Women's health

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEXUAL BEHAVIOR; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR;

ADOLESCENT; ADULT; BRAZIL; CHILD; FEMALE; HUMANS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEXUAL BEHAVIOR; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS;

EID: 57749099124     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2008001200017     Document Type: Article

References (41)

1. International Agency for Research on Cancer. Cervix cancer screening. Lyon: IARC Press; 2005. (IARC Handbooks of Cancer Prevention, 10).
2. Parkin DM, Whelan SL, Feraly J, Teppo L, Thomas DB, editors. Cancer incidence in five continents. v. VIII. Lyon: IARC Press; 2002.
3. Ferenczy A, Franco EL. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002; 3:11-6.
4. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286:3106-14.
5. National Institutes of Heath Consensus Development Conference statement on cervical cancer. Gynecol Oncol 1996; 66: 351-61.
6. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-26.
7. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-9.
8. Mount SL, Papillo JL. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England. Pediatrics 1999; 103:539-45.
9. Simsir A, Brooks S, Cochran L, Bourquin P, Ioffe OB. Cervicovaginal smear abnormalities in sexually active adolescents: implications for management. Acta Cytol 2002; 46:271-6.
10. Silva CS, Souza MAH, Angelo AG, Pavani RS, Adad J, Murta EFC. Increased frequency of abnormal Papanicolaou smears in adolescents. Arch Gynecol Obstet 2002; 266:154-6.
11. Longatto Filho A, Etlinger D, Gomes N, Cruz SV, Cavalieri MJ. Freqüência de esfregaços cérvicovaginais anormais em adolescentes e adultas: revisão de 308.630 casos. Rev Inst Adolfo Lutz 2003; 62:31-4.
12. Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004; 189:46-50.
13. Frega A, Stentella P, De Ioris A, Piazze JJ, Fambrini M, Marchionni M, et al. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence. Cancer Lett 2003; 196:127-34.
14. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003; 168:421-5.
15. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24(3 Suppl):42-51.
16. Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee SK, Kuypers JM, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005; 191:731-8.
17. Richart RM. A theory of cervical carcinogenesis. Obstet Gynecol Surv 1969; 24(7 Pt 2):874-9.
18. Organização Mundial da Saúde. Problemas de saúde na adolescência. Geneva: Organização Mundial da Saúde; 1965. (Série de Informes Técnicos, 318).
19. Henry MR. The Bethesda System 2001: an update of new terminology for gynecologic cytology. Clin Lab Med 2003; 23:585-603.
20. Edelman M, Fox AS, Alderman EM, Neal W, Shapiro A, Silver EJ, et al. Cervical Papanicolaou smear abnormalities in inner city Bronx adolescents: prevalence, progression, and immune modifiers. Cancer 1999; 87:184-9.
21. Halcon LL, Lifson AR, Shew M, Joseph M, Hannan PJ, Hayman CR. Pap test results among lowincome youth: prevalence of dysplasia and practice implications. J Obstet Gynecol Neonatal Nurs 2002; 31:294-304.
22. Prussia PR, Gay GH, Bruce A. Analysis of cervicovaginal (Papanicolaou) smears, in girls 18 years and under. West Indian Med J 2002; 51:37-9.
23. d'Ottaviano-Morelli MG, Zeferino L, Cecatti JG, Terrabuio DR, Martinez EZ. Prevalence of cervical intraepithelial neoplasia and invasive carcinoma based on cytological screening in the region of Campinas, São Paulo, Brazil. Cad Saúde Pública 2004; 20:153-9.
24. Bleyer A, O'Leary M, Barr M, Ries LAG, editors. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. Bethesda: National Cancer Institute; 2006.
25. Sadeghi SB, Hsieh EW, Gunn SW. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Am J Obstet Gynecol 1984; 148:726-9.
26. Utagawa ML, Pereira SM, Cavaliere MJ, Maeda MY, Shih LW, Shirata NK. Cervical intraepithelial neoplasia in adolescents: study of cytological findings between 1987 and 1995 in Sao Paulo State-Brazil. Arch Gynecol Obstet 1998; 262:59-64.
27. Ho GYF, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, et al. Risk factors for subsequent cervicovaginal human papillomavirus infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 2002; 186:737-42.
28. Chan JK, Monk BJ, Brewer C, Keefe KA, Osann K, McMeekin S, et al. HPV infection and number of lifetime sexual partners are strong predictors for natural regression of CIN 2 and 3. Br J Cancer 2003; 89:1062-6.
29. Leal EAS, Leal Júnior OS, Guimarães MH, Vitoriano MN, Nascimento TL, Costa OLN. Lesões precursoras do câncer de colo em mulheres adolescentes e adultas jovens do Município de Rio Branco - Acre. Rev Bras Ginecol Obstet 2003; 25:81-6.
30. Kahn JA, Rosenthal SL, Succop PA, Ho GYF, Burk RD. The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr 2002; 141:718-23.
31. Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer 1999; 85:1139-44.
32. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31:14-9.
33. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003; 95:1336-43.
34. Wright JD, Davila RM, Pinto KR, Merritt DF, Gibb RK, Rader JS, et al. Cervical dysplasia in adolescents. Obstet Gynecol 2005; 106:115-20.
35. Monteiro DL, Trajano AJ, Silva KS, Russomano FB. Pre-invasive cervical disease and uterine cervical cancer in Brazilian adolescents: prevalence and related factors. Cad Saúde Pública 2006; 22:2539-48.
36. Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364:1678-83.
37. Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002; 325:572.
38. Instituto Nacional de Câncer. Viva mulher. Programa de controle do câncer do colo do útero: manual de implantação do programa. Rio de Janeiro: Instituto Nacional de Câncer; 1997.
39. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52:342-62.
40. American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. ACOG Committee opinion #300: cervical cancer screening in adolescents. Obstet Gynecol 2004; 104:885-9.
41. International Agency for Research on Cancer/Alliance for Cervical Cancer Prevention. Planning and implementing cervical cancer prevention and control programs: a manual for managers. Seattle: Alliance for Cervical Cancer Prevention; 2004.